WNT/β-CATENIN has previously been implicated in FSHD pathology and positively correlates with the regulation of CASP3-mediated apoptosis in FSHD muscle biopsies (Banerji et al., 2015). This evidence concerns the gene CASP3 and facioscapulohumeral muscular dystrophy.